Can Life Insurance Proceeds from China Be Remitted Overseas?

A surprisingly common question comes up in cross-border estate and insurance planning: parents live in China, they buy a life insurance policy from a Chinese insurer, and they name a child living overseas as beneficiary. Years later, a claim is paid. Can the proceeds actually be converted into foreign currency and sent abroad?

One answer circulates online all the time: medical, accident and critical illness insurance are “current-account” items, so the money can be remitted; life insurance and participating policies are “capital-account” items, so the money cannot.

That sounds neat. It is also too neat.

The problem is that it collapses two very different transactions into one.

Using RMB in China to buy an offshore life insurance product is one transaction. Receiving proceeds from a Chinese insurance policy and remitting those proceeds to an overseas beneficiary is another.

Those are not the same foreign-exchange issue.

Start with the first scenario. If a resident in China wants to convert RMB into foreign currency and use it to buy an offshore life insurance policy, savings-type policy or participating investment-return insurance product, Chinese foreign-exchange rules do impose restrictions. SAFE guidance expressly states that personal foreign-exchange purchases may not be used for offshore property purchases, securities investment, or life insurance and investment-return insurance products that fall within capital-account activities not yet opened to individuals.

That rule is real. But notice what it regulates: money leaving China to purchase an offshore insurance product.

It does not automatically answer a different question: what happens when a Chinese insurer pays a legitimate claim to a beneficiary who is treated as an overseas individual for foreign-exchange purposes?

SAFE has addressed that point directly.

In its personal foreign-exchange guidance, the Xiamen branch first explains that offshore life insurance and investment-return participating insurance are treated as financial and capital-account transactions that are not generally open under the current regime. On the very same page, it asks another question: if the insurance beneficiary is an overseas individual, can the claim proceeds be purchased into foreign currency and remitted abroad?

The answer is not “no, because it came from life insurance.” Instead, the guidance says the legality of the underlying insurance arrangement matters. If the insurance was purchased lawfully and the payment is legitimate, the proceeds may be handled under the rules governing lawful RMB income received in China by an overseas individual, subject to supporting documentation.

That distinction matters.

Suppose Mr. Wang has RMB 5 million in China and wants to convert it into U.S. dollars to buy a savings-type policy in Hong Kong. He is using domestic funds to acquire an offshore financial product. Foreign-exchange controls on the use of purchased foreign currency are directly engaged.

Now change the facts. Mr. Wang bought a policy years ago from a Chinese insurer. His son, who qualifies as an overseas individual for foreign-exchange purposes, is the named beneficiary. After the insured event occurs, the Chinese insurer pays RMB 5 million under the contract.

The son is not using RMB to buy insurance offshore. He is receiving insurance proceeds under an existing contract. Treating the two situations as identical simply because both involve the words “life insurance” misses the legal character of the transaction.

More recent SAFE responses point in the same direction. In June 2026, the Yunnan branch responded to a question about a large life insurance policy issued in China with an overseas child as beneficiary. The response referred to the rules for lawful RMB income received in China by an overseas individual: with valid identification and documents showing the source and amount of the funds, foreign currency may be purchased through a bank.

The Henan branch has given a similarly practical answer in insurance cases: where the underlying insurance arrangement is lawful, an overseas beneficiary may apply to convert and remit the proceeds by presenting documents such as identification, the insurance contract and the insurer’s payment evidence.

There is another point that is easy to miss: “my child lives overseas” is not the same thing as “my child is an overseas individual” under China’s foreign-exchange rules.

A Chinese citizen may have lived in the United States, Singapore or the United Kingdom for years and still be treated differently from a foreign citizen or another person who falls within the regulatory definition of an overseas individual. The documents used for the transaction matter.

So in a real case, the useful questions are not just “Is this a life policy?” or “Does the beneficiary live abroad?” The bank will care about who owns the policy, who is insured, who is legally entitled to the proceeds, what status the beneficiary has for foreign-exchange purposes, and whether the payment can be documented as genuine and lawful.

For a large claim, expect the bank to review the transaction background. The insurance contract, claim settlement notice, proof of payment, beneficiary identification and, where relevant, tax documents may all come into play.

Restrictions on using RMB to buy offshore life insurance do not automatically mean that proceeds from a lawful Chinese insurance policy can never be remitted to an overseas beneficiary. These are different transactions, and the remittance analysis turns on the beneficiary’s status, the legality of the policy and claim, and the supporting documents presented to the bank.

So the real dividing line is not simply “medical insurance versus life insurance.” It is what the money is actually being used for and why the recipient is legally entitled to receive it.